966P Potential role of neuropilin-1 in the prognosis, development and risk of invasion in hepatocellular carcinoma patients

Authors: Payo-Serafín, T., Fernández Palanca, P., Méndez Blanco, C., San-Miguel, B., Tuñón, M.J., González-Gallego, J., Mauriz, J.L.

Source: In Annals of Oncology October 2023 34 Supplement 2:S601-S601

180P A systematic review with meta-analysis of risks and benefits of tyrosine kinase inhibitors in hepatocellular carcinoma treatment.

Authors: Martínez-Geijo, J.¹ (AUTHOR), Payo-Serafín, T.¹ (AUTHOR), Méndez-Blanco, C.¹ (AUTHOR), Palanca, P. Fernández¹ (AUTHOR), Palomo-Pérez, A. García¹ (AUTHOR), Ortiz de Urbina González, J.J.¹ (AUTHOR), San-Miguel, B.¹ (AUTHOR), Tuñón, M.J.¹ (AUTHOR), Mauriz, J.L.¹ (AUTHOR)

Source: Annals of Oncology. 2024 Supplement 1, Vol. 35, pS81-S81. 1p.

Subject Terms: *PROTEIN-tyrosine kinase inhibitors, *HEPATOCELLULAR carcinoma